Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-004103
Filing Date
2025-02-11
Accepted
2025-02-11 14:59:22
Documents
1
Period of Report
2025-02-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7027
  Complete submission text file 0001127602-25-004103.txt   8624
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2000 GALLOPING HILL RD KENILWORTH NJ 07033
Business Address
Oosthuizen Johannes Jacobus (Reporting) CIK: 0001916310 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 25609267